Clinical Trial: Low Dose Vasopressin in Traumatic Shock

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: Prospective, Randomized, Double-Blind, Multi-Center Trial of Low Dose Vasopressin Versus Placebo in Traumatic Shock Resuscitation

Brief Summary: Hypothesis: We hypothesize that resuscitation regimens which minimize the total volume of resuscitation fluid, while restoring organ perfusion, will lead to lower morbidity and mortality in critically ill patients following trauma.

Detailed Summary:
Sponsor: The University of Texas Health Science Center at San Antonio

Current Primary Outcome: The Primary Endpoint of This Study Will be Day 30 Mortality. [ Time Frame: 30 days ]

Original Primary Outcome: Our primary objective, therefore, is straightforward: to develop new resuscitation regimens that are beneficial in limiting organ dysfunction and mortality after severe injury

Current Secondary Outcome: Secondary Objective is to Better Understand the Efficacy of Novel Endpoints of Resuscitation in the Management of Shock and the Ability of These Monitors to Predict Outcome After Trauma. [ Time Frame: 28 days ]

Original Secondary Outcome: Secondary Objective is to Better Understand the Efficacy of Novel Endpoints of Resuscitation in the Management of Shock and the Ability of These Monitors to Predict Outcome After Trauma.

Information By: The University of Texas Health Science Center at San Antonio

Dates:
Date Received: January 9, 2007
Date Started: February 2007
Date Completion:
Last Updated: April 16, 2013
Last Verified: April 2013